CHICAGO--(BUSINESS WIRE)--CytoCore (OTCBB:CYCR), the biopharmaceutical research and medical device company concentrating on early detection and treatment of reproductive-tract cancers, today announced the online availability of Chief Scientist Dr. George Gorodeski’s presentation at the company shareholders meeting in San Francisco on June 21st.
